Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

01/08/2018 04:00

Aug 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               71.24               60.91           277.00    
                   (+17.0 pct)         (+3.7 pct)       (+5.8 pct)  
  Operating           17.98               14.28            61.50    
                   (+26.0 pct)         (-17.2 pct)      (+1.3 pct)  
  Pretax              19.43               15.80            65.00    
                   (+23.0 pct)         (-13.4 pct)      (+1.7 pct)  
  Net                 15.24               11.77            50.50    
                   (+29.4 pct)         (-13.9 pct)      (+0.4 pct)  
  EPS Basic         29.64 yen           22.31 yen        98.23 yen  
  EPS Diluted       29.63 yen           22.31 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div                               25.00 yen        22.50 yen  
  -Q4 Div                               20.00 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T